Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients

Stroke. 2007 Jan;38(1):192-3. doi: 10.1161/01.STR.0000251788.03914.00. Epub 2006 Nov 16.

Abstract

Background and purpose: Recanalization rates after the intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment have been poorly studied in acute stroke.

Methods: CT angiography was performed before IV rt-PA in all patients and digital subtraction angiography was undertaken for intra-arterial thrombolysis in cases of no improvement after rt-PA infusion.

Results: Forty-five patients were treated with IV rt-PA. Initial CT angiography showed relevant arterial occlusions in 35 patients. Recanalization after rt-PA therapy was demonstrated by digital subtraction angiography in 7 of the 31 patients with the occlusion on initial CT angiography: 2/16 in the internal carotid or proximal middle cerebral artery, 3/11 in the distal middle cerebral artery and 2/4 in the basilar artery occlusion.

Conclusions: The early recanalization rate after IV rt-PA use was very low in cases with large proximal arterial occlusions. CT angiography before IV rt-PA may be useful for the prediction of its efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiography, Digital Subtraction / methods
  • Angiography, Digital Subtraction / standards
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / physiopathology
  • Cerebral Angiography / methods*
  • Cerebral Angiography / standards
  • Cerebral Arteries / diagnostic imaging*
  • Cerebral Arteries / drug effects*
  • Cerebral Arteries / physiopathology
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Predictive Value of Tests
  • Preoperative Care / methods
  • Preoperative Care / standards
  • Recombinant Fusion Proteins / administration & dosage
  • Retrospective Studies
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Stroke / physiopathology
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage*
  • Tomography, X-Ray Computed / methods
  • Tomography, X-Ray Computed / standards
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Fusion Proteins
  • Tissue Plasminogen Activator